Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

AML · Acute Myeloid Leukemia · AML, Adult Recurrent · AML, Adult

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

District One Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (SAMI XI, dr) · SFM@districtonehospital.com · +14012275001

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

AML · MDS · Acute Leukemia

Abroad (travel likely)RecruitingPHASE2

Minneapolis, United States

Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)

Acute Myeloid Leukemia · AML, Adult · Acute Myeloid Leukemia, Adult

Abroad (travel likely)Recruiting

San Giovanni Rotondo, Italy · Sassari, Italy

Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

AML, Adult

Abroad (travel likely)RecruitingPHASE1

Hangzhou, China

DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML

AML (Acute Myeloid Leukemia)

Abroad (travel likely)RecruitingPHASE3

Kunming, China